Publication Archives: 2025
-
(2025)
Ademoye, T., Ganegamage, S., Masoudi, B. et al.
In Vitro Evaluation of Amide-Linked Coumarin Scaffolds for the Inhibition of α-Synuclein and Tau Aggregation
ACS Omega 2025, XXXX, XXX, XXX-XXX, DOI: 10.1021/acsomega.5c02435
-
(2025)
Fils, A., Ambamba, B., Njayou, F., et al.
Khaya grandifololia exerts multitarget neuroprotective potential against neurodegenerative disorders: In vitro and in silico studies
IBR (2025) 19, 400-408 DOI: 10.1016/j.ibneur.2025.08.007
-
(2025)
Kurt W., Whitcomb K. et al.
Physical and Mechanical Properties of Monomeric Alpha-Synuclein Provide Leads to Molecular Function
J. Phys. Chem. B 2025, XXXX, XXX, XXX-XXX DOI: 10.1021/acs.jpcb.5c03200
-
(2025)
Yasuhiko I., Naoto K., Akinori A., et al.
Perilla-derived chalcone inhibits α-synuclein fibrillization and prevents aggregate-induced disruption of intracellular α-synuclein conformation in neuronal cells
Science Direct (2025) (779), DOI: 10.1016/j.bbrc.2025.152452.
-
(2025)
Qu, X., Lin, L., Li, Y. et al.
N6-methyladenosine RNA modification regulates microglial phagocytosis in the APP/PS1 mouse model of Alzheimer’s disease
Genes Immun (2025). DOI: 10.1038/s41435-025-00347-1
-
(2025)
Chunhui, H., Dilin, X., Zhang, Ke. et al.
Investigating the Interactions of a Cyclic Peptide Hormone Somatostatin and Its Derivatives on Amyloid-Beta Aggregation
ACS Chem. Neurosci. 2025, XXXX, XXX, XXX-XXX DOI: 10.1021/acschemneuro.5c00044
-
(2025)
Perez-Corredor, P., Arevalo-Alquichire, S., Mazzarino, R., et al.
ApoE3 Christ church and tau interaction as a protective mechanism against Alzheimer’s disease
Alzheimer’s & Dementia (2025), 21 (7), e70396 DOI: 10.1002/alz.70396
-
(2025)
de Oliveira, A.P., Baghel, D., Holcombe, B. et al.
Lipid mediated formation of antiparallel aggregates in cerebral amyloid angiopathy
Acta Neuropathol 150, 3 (2025). DOI: 10.1007/s00401-025-02911-5
-
(2025)
Frigerio, I., Morella, M.L., Winkelaar, A.B. et al.
Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson’s disease
Nat Commun 16, 6630 (2025). DOI: 10.1038/s41467-025-61052-1
-
(2025)
Galeotti, Santucci, Klimek et al
The tau isoform 1N4R confers vulnerability of MAPT knockout human iPSC-derived neurons to amyloid beta and phosphorylated tau-induced neuronal dysfunction
Alzheimer’s Association 12, (2025). DOI: 10.1002/alz.14403
